Board Meeting26 Mar 2026, 10:26 am

Sudeep Pharma Ltd Announces Trading Window Closure from 1st April 2026

AI Summary

Sudeep Pharma Ltd has announced the closure of the trading window for designated persons from 1st April 2026. The closure is in accordance with the Code of Conduct on Prevention of Insider Trading of Sudeep Pharma Limited and SEBI (Prohibition of Insider Trading) Regulations, 2015. The trading window will remain closed till 48 hours after the declaration of the Audited Standalone and Consolidated Financial Results for the year ending on March 31, 2026. This means that all Designated Persons and their immediate relatives are prohibited from dealing in the securities of the Company during this period. The date of the meeting of the Board of directors to approve the Audited Standalone & Consolidated Financial Results for the year ending on March 31, 2026, will be intimated separately.

Key Highlights

Trading window closure for designated persons from 1st April 2026
Closure in accordance with the Code of Conduct on Prevention of Insider Trading and SEBI Regulations
Prohibition of dealing in securities for Designated Persons and their immediate relatives during the closure period
Closure to remain till 48 hours after the declaration of the Audited Standalone and Consolidated Financial Results for the year ending on March 31, 2026
Date of the Board meeting to approve the Audited Financial Results to be intimated separately

View BSE Filing

SUDEEPPHRM

Pharmaceuticals

Sudeep Pharma Ltd

Price Impact